183 related articles for article (PubMed ID: 32300648)
1. Germline mutation of
Toufektchan E; Lejour V; Durand R; Giri N; Draskovic I; Bardot B; Laplante P; Jaber S; Alter BP; Londono-Vallejo JA; Savage SA; Toledo F
Sci Adv; 2020 Apr; 6(15):eaay3511. PubMed ID: 32300648
[TBL] [Abstract][Full Text] [Related]
2. p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes.
Rakotopare J; Toledo F
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834388
[TBL] [Abstract][Full Text] [Related]
3. Mutant mice lacking the p53 C-terminal domain model telomere syndromes.
Simeonova I; Jaber S; Draskovic I; Bardot B; Fang M; Bouarich-Bourimi R; Lejour V; Charbonnier L; Soudais C; Bourdon JC; Huerre M; Londono-Vallejo A; Toledo F
Cell Rep; 2013 Jun; 3(6):2046-58. PubMed ID: 23770245
[TBL] [Abstract][Full Text] [Related]
4. p53 Mediates Failure of Human Definitive Hematopoiesis in Dyskeratosis Congenita.
Fok WC; Niero ELO; Dege C; Brenner KA; Sturgeon CM; Batista LFZ
Stem Cell Reports; 2017 Aug; 9(2):409-418. PubMed ID: 28757166
[TBL] [Abstract][Full Text] [Related]
5. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.
Guo Y; Kartawinata M; Li J; Pickett HA; Teo J; Kilo T; Barbaro PM; Keating B; Chen Y; Tian L; Al-Odaib A; Reddel RR; Christodoulou J; Xu X; Hakonarson H; Bryan TM
Blood; 2014 Oct; 124(18):2767-74. PubMed ID: 25205116
[TBL] [Abstract][Full Text] [Related]
6. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
Ballew BJ; Savage SA
Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
[TBL] [Abstract][Full Text] [Related]
7. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T
Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522
[TBL] [Abstract][Full Text] [Related]
8. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.
Tummala H; Walne A; Collopy L; Cardoso S; de la Fuente J; Lawson S; Powell J; Cooper N; Foster A; Mohammed S; Plagnol V; Vulliamy T; Dokal I
J Clin Invest; 2015 May; 125(5):2151-60. PubMed ID: 25893599
[TBL] [Abstract][Full Text] [Related]
9. Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP).
Lagunas AM; Francis M; Maniar NB; Nikolova G; Wu J; Crowe DL
Mol Cancer Res; 2019 Jul; 17(7):1480-1492. PubMed ID: 31043491
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance and cell cycle regulation in spontaneously immortalized T-cell lines from Nijmegen breakage syndrome patients.
Siwicki JK; Degerman S; Chrzanowska KH; Roos G
Exp Cell Res; 2003 Jul; 287(1):178-89. PubMed ID: 12799193
[TBL] [Abstract][Full Text] [Related]
11. The long and the short of it: the MDM4 tail so far.
Haupt S; Mejía-Hernández JO; Vijayakumaran R; Keam SP; Haupt Y
J Mol Cell Biol; 2019 Mar; 11(3):231-244. PubMed ID: 30689920
[TBL] [Abstract][Full Text] [Related]
12. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment.
Hartwig FP; Collares T
Ageing Res Rev; 2013 Mar; 12(2):642-52. PubMed ID: 23541441
[TBL] [Abstract][Full Text] [Related]
13. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability.
Le Guen T; Jullien L; Touzot F; Schertzer M; Gaillard L; Perderiset M; Carpentier W; Nitschke P; Picard C; Couillault G; Soulier J; Fischer A; Callebaut I; Jabado N; Londono-Vallejo A; de Villartay JP; Revy P
Hum Mol Genet; 2013 Aug; 22(16):3239-49. PubMed ID: 23591994
[TBL] [Abstract][Full Text] [Related]
14. De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome.
Toki T; Yoshida K; Wang R; Nakamura S; Maekawa T; Goi K; Katoh MC; Mizuno S; Sugiyama F; Kanezaki R; Uechi T; Nakajima Y; Sato Y; Okuno Y; Sato-Otsubo A; Shiozawa Y; Kataoka K; Shiraishi Y; Sanada M; Chiba K; Tanaka H; Terui K; Sato T; Kamio T; Sakaguchi H; Ohga S; Kuramitsu M; Hamaguchi I; Ohara A; Kanno H; Miyano S; Kojima S; Ishiguro A; Sugita K; Kenmochi N; Takahashi S; Eto K; Ogawa S; Ito E
Am J Hum Genet; 2018 Sep; 103(3):440-447. PubMed ID: 30146126
[TBL] [Abstract][Full Text] [Related]
15. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
He H; Wang Y; Guo X; Ramchandani S; Ma J; Shen MF; Garcia DA; Deng Y; Multani AS; You MJ; Chang S
Mol Cell Biol; 2009 Jan; 29(1):229-40. PubMed ID: 18936156
[TBL] [Abstract][Full Text] [Related]
16. The molecular genetics of the telomere biology disorders.
Bertuch AA
RNA Biol; 2016 Aug; 13(8):696-706. PubMed ID: 26400640
[TBL] [Abstract][Full Text] [Related]
17. [Dangerous liaisons: p53, dyskeratosis congenita and Fanconi anemia].
Toufektchan E; Jaber S; Toledo F
Med Sci (Paris); 2017 Jan; 33(1):95-98. PubMed ID: 28120765
[No Abstract] [Full Text] [Related]
18. DNA damage response, checkpoint activation and dysfunctional telomeres: face to face between mammalian cells and Drosophila.
Cipressa F; Cenci G
Tsitologiia; 2013; 55(4):211-7. PubMed ID: 23875450
[TBL] [Abstract][Full Text] [Related]
19. Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres.
Roake CM; Artandi SE
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28289249
[TBL] [Abstract][Full Text] [Related]
20. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
